What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Enzyme
- Gene
Moussa B.H. Youdim mainly focuses on Neuroprotection, Pharmacology, Biochemistry, Oxidative stress and Dopamine.
The Neuroprotection study combines topics in areas such as Neurotoxicity, Antioxidant, Parkinson's disease, MPTP and Catechin.
His Pharmacology study incorporates themes from Anesthesia, Selegiline, Monoamine oxidase B, Rasagiline and Polyphenol.
The various areas that Moussa B.H. Youdim examines in his Biochemistry study include Chelation and Amyloid precursor protein.
His Oxidative stress study integrates concerns from other disciplines, such as Iron Chelating Agents, Reactive oxygen species, Neurodegeneration, Alzheimer's disease and Biological activity.
Endocrinology and Internal medicine are the areas that his Dopamine study falls under.
His most cited work include:
- Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. (1202 citations)
- Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases (612 citations)
- Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration. (469 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Pharmacology, Neuroprotection, Internal medicine, Endocrinology and Monoamine oxidase.
His studies deal with areas such as Neurotrophic factors, Selegiline, Monoamine oxidase B, MPTP and Rasagiline as well as Pharmacology.
His Neuroprotection study combines topics in areas such as Oxidative stress, Biochemistry, Neurodegeneration and Parkinson's disease.
The concepts of his Endocrinology study are interwoven with issues in Receptor and Binding protein.
His biological study spans a wide range of topics, including Tyramine, Cholinesterase and Serotonin.
His Neuroscience research incorporates elements of Alzheimer's disease and Disease.
He most often published in these fields:
- Pharmacology (40.43%)
- Neuroprotection (34.41%)
- Internal medicine (32.90%)
What were the highlights of his more recent work (between 2007-2020)?
- Neuroprotection (34.41%)
- Pharmacology (40.43%)
- Oxidative stress (16.13%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Neuroprotection, Pharmacology, Oxidative stress, Neuroscience and Monoamine oxidase.
His Neuroprotection research integrates issues from Neurodegeneration, Parkinson's disease, Disease, Rasagiline and Amyloid precursor protein.
His Neurodegeneration research is classified as research in Internal medicine.
Moussa B.H. Youdim has included themes like Neurotrophic factors, Dopamine, Monoamine oxidase B and Monoamine oxidase inhibitor in his Pharmacology study.
His Oxidative stress research entails a greater understanding of Biochemistry.
His study explores the link between Monoamine oxidase and topics such as Ladostigil that cross with problems in Protein kinase A.
Between 2007 and 2020, his most popular works were:
- Neuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties. (175 citations)
- Simultaneous manipulation of multiple brain targets by green tea catechins: a potential neuroprotective strategy for Alzheimer and Parkinson diseases. (158 citations)
- Cell signaling pathways and iron chelation in the neurorestorative activity of green tea polyphenols: special reference to epigallocatechin gallate (EGCG). (134 citations)
In his most recent research, the most cited papers focused on:
- Enzyme
- Internal medicine
- Gene
His primary areas of study are Neuroprotection, Pharmacology, Monoamine oxidase, Oxidative stress and Rasagiline.
His Neuroprotection research includes elements of Biochemistry, Amyloid precursor protein, Ladostigil, Dopamine and Animal data.
His study in Pharmacology is interdisciplinary in nature, drawing from both Neurotrophic factors, Dementia, Monoamine oxidase B and Monoamine oxidase inhibitor.
His research in Monoamine oxidase intersects with topics in Antidepressant and In vitro.
His Oxidative stress research is multidisciplinary, incorporating elements of Neurotoxicity and Iron Chelating, Antioxidant.
His Rasagiline research is multidisciplinary, incorporating perspectives in Selegiline and Protein kinase C.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
